Skip to main content

Now Accepting New Patients

Cancer Screening

The smartest way to screen for cancer.

Proactive, private screening with next-generation diagnostics. No GP referral needed.

Book a consultation
CQC RegulatedUKAS-Accredited LabsGP-Reviewed Results

Results reviewed by our GPs

Why screen privately?

Results in days, not months

Fast turnaround from UKAS-accredited laboratories.

No GP gatekeeping

Self-refer directly. No waiting for a referral letter.

Doctor-reviewed, every time

Every result personally reviewed by an AtWell GP.

Featured Test

Stockholm3. The future of prostate screening.

A next-generation blood test combining protein biomarkers, genetic markers, and clinical data — developed at the Karolinska Institute.1

3× moreprecisethan standard PSA screening2
52%fewer unnecessary biopsies1
90,000+men validated across global trials3

How Stockholm3 works

🩸
One blood draw
Simple venous sample
5 protein biomarkers + 101 genetic markers
Including PSA, KLK2, GDF15 + polygenic risk score
AI algorithm
Combined with clinical data
Risk score 1–100
Clear, actionable result

Stockholm3 vs traditional PSA

PSA alone

Single marker — not cancer-specific
High false-positive rate (75–80%)4
Leads to unnecessary biopsies
Misses cancers at low PSA levels

Stockholm3Recommended

Multi-marker — proteins + genetics + clinical data
52% fewer false positives1
Validated across all ethnicities2
Included in EAU & AUA guidelines3

Understanding your results

Low Risk

Very low probability of clinically significant cancer. Retest in 6 years.

Normal Risk

Some risk within normal range for age. Retest in 2 years.

Elevated Risk

Further investigation recommended. MRI referral arranged.

Book a consultation with our GP to discuss which screening is right for you

Book a consultation
Full range

We also screen for

Bowel cancer screening

FIT test — simple, non-invasive

Ovarian markers

CA125 blood test

Cervical screening

HPV + liquid-based cytology

Skin cancer check

Dermoscopy assessment

General cancer markers

Comprehensive tumour marker panel

Get started

Book a screening consultation

Start with a 30-minute GP consultation. Your doctor will review your health history, discuss which screenings are right for you, and build a personalised plan.

  • Personalised screening plan
  • GP-reviewed results
  • Follow-up consultation included
Book a consultation
Your journey

Four simple steps

1

Book

Book a 30-minute screening consultation online or call us.

2

Attend

30-minute appointment at our Balsall Common clinic.

3

Lab analysis

Samples processed at UKAS-accredited laboratories.

4

Results

GP-reviewed results + follow-up consultation included.

1 in 2 people will develop cancer in their lifetime. Early detection changes everything.5

90%survival at stage 15
vs
15%survival at stage 45

Better to know.

Questions

Frequently asked

Stockholm3 is a blood test developed at the Karolinska Institute that combines five protein biomarkers, 101 genetic markers, and your clinical data into an AI-powered risk score for clinically significant prostate cancer. It’s far more accurate than PSA alone, reducing unnecessary biopsies by up to 52%.1

The NHS does not currently offer a routine prostate cancer screening programme, and Stockholm3 is not yet available through the NHS. At AtWell, you can self-refer for Stockholm3 and other advanced screenings without waiting for a GP referral. Results are typically available within two weeks.

Men aged 45–74 who haven’t been diagnosed with prostate cancer. It’s particularly valuable if you have a family history of prostate cancer, are of African or African-Caribbean ancestry, or have had a borderline PSA result.

No. All our cancer screenings are available as self-referral. You can book directly online or by calling 01676 545 111. Every result is reviewed by an AtWell GP before being shared with you.

Most blood-based screening results are available within 5–10 working days. Stockholm3 results typically take up to two weeks as samples are processed by TDL Pathology. You’ll receive a call from your GP to discuss your results.

Your AtWell GP will discuss the result with you in detail and arrange an onward referral — either to an NHS consultant or a private specialist, depending on your preference. We support you throughout the process.

Take control of your health.

Proactive screening. Next-generation diagnostics. GP-reviewed results.

Book a consultation

Or call us on 01676 545 111

  1. Grönberg H, et al. Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study. Lancet Oncology, 2015;16(16):1667–76.
  2. Vigneswaran HT, et al. SEPTA trial: Stockholm3 evaluation in a multi-ethnic North American cohort. Journal of Urology, 2025.
  3. Stockholm3 combined trial data. stockholm3.com. Accessed April 2025.
  4. NICE Medtech Innovation Briefing MIB303: Stockholm3 for prostate cancer screening. nice.org.uk, 2023.
  5. Cancer Research UK. Cancer incidence and survival statistics. cancerresearchuk.org, 2024.
Book a screening consultation